🇺🇸 FDA
Pipeline program

Ramelteon (RozeremR)

5276/21/051

Approved small_molecule terminated

Quick answer

Ramelteon (RozeremR) for Insomnia is a Approved program (small_molecule) at TAKEDA PHARMACEUTICAL CO LTD with 1 ClinicalTrials.gov record(s).

Program details

Company
TAKEDA PHARMACEUTICAL CO LTD
Indication
Insomnia
Phase
Approved
Modality
small_molecule
Status
terminated

Clinical trials